Abstract
Purpose. To quantify the advantage gained by direct administration to a target site for two non-steroidal anti-inflammatory drugs (NSAIDs) piroxicam and diclofenac in the rat air pouch model of inflammation. To derive a model relating drug targeting index (DTI) to the pharmacokinetic parameters of the target and systemic sites, and to compare predictions with observations.
Methods. DTI was calculated based on area under the concentration time curve at target (pouch) and systemic site (venous blood) following administration into and sampling from both sites. A model was derived relating DTI to systemic clearance, target permeability, plasma protein binding and fraction of the targeted dose that is systemically available.
Results. Both NSAIDs exhibited linear pharmacokinetics over the dose ranges studies. They differed primarily in total body clearance which was approximately 16 fold greater for diclofenac (213 ml hr−l per 250 g) than piroxicam (13 ml hr−l per 250 g). Observed DTIs (11, 114 and 276 for piroxicam, S[ + ]ibuprofen [studied previously] and diclofenac) were ranked in order of total body clearance but were approximately 7.5 fold lower than predicted (101, 700 and 2214 respectively).
Conclusions. The discrepancy was explained by the influx of the plasma binding protein, albumin, into the target site due to increased vascular permeability associated with the inflammatory response. The originally derived equation for DTI, which assumed only unbound drug diffuses across the target site, was modified to take into account the simultaneous flux of bound drug.
Similar content being viewed by others
REFERENCES
H-S. G. Chen and J. F. Gross. Intra-arterial infusion of anticancer drugs: Theoretic aspects of drug delivery and review of responses. Cancer. Treat. Rev. 64:31–40 (1980).
W. W. Eckman, C. S. Patlak and J. D. Fenstermacher. A critical evaluation of the principles governing the advantages of intra-arterial infusions. J. Pharmacokinet. Biopharm. 2:257–284 (1974).
E. Tomlinson. Theory and practice of site-specific drug delivery. Adv. Drug. Deliv. Rev. 1:87–198 (1987).
A. Boddy and L. J. Aarons. Pharmacokinetic and pharmacodynamic aspects of site-specific drug delivery. Advanced Drug Delivery Reviews 3:155–163 (1989).
C. A. Hunt, R. D. Macgregor and R. A. Siegel. Engineering targeted in vivo drug delivery I. The physiological and physiochemical principles governing opportunities and limitations. Pharm. Res. 3:333–344 (1986).
U. G. Ericksson and T. N. Tozer. Pharmacokinetic evaluation of regional drug delivery. Acta Pharm. Jugosl. 37: 331–344 (1987).
A. J. Stevens, S. W. Martin, B. S. Brennan, M. Rowland and J. B. Houston. Experimental determination of a drug targeting index for S(+) ibuprofen using the rat air pouch model of inflammation. J. Drug Targeting. 2:333–340 (1994).
S. W. Martin, A. J. Stevens, B. S. Brennan, D. Davies, M. Rowland and J. B. Houston. The six-day-old rat air pouch model of inflammation: Characterisation of the inflammatory response to carrageenan. J. Pharmacol. Toxicol. Methods. 32:139–148 (1994).
S. W. Martin, A. J. Stevens, B. S. Brennan, M. Rowland and J. B. Houston. Pharmacodynamic comparison of region drug delivery for nonsteroidal anti-inflammatory drugs using the air pouch of inflammation. J. Pharm. Pharmac. 47:458–461, (1995).
F. D. Boudinot and S. S. Ibrahim. High performance liquid chromatographic assay for piroxicam in human plasma. J. Chromatogr. 430:424–428 (1988).
J. Godbillon, S. Gauron and J. P. Metayer. High performance liquid chromatographic determination of diclofenac and its monohydroxylated metabolites in biological fluids. J. Chromatogr. 338:151–159 (1985).
M. Gibaldi and D. Perrier. Pharmacokinetics. 2nd Edition. Marcel Dekker, New York.
S. W. Martin, A. J. Stevens, B. S. Brennan, M. Ries, L. Gifford, M. Rowland and J. B. Houston. Regional Drug Delivery I: Permeability characteristics of the Rat 6-day-old air pouch model of inflammation. Pharm. Res. 12:1980–1986 (1995).
L. K. Roskos and F. D. Boudinot. Effects of dose and sex on the pharmacokinetics of piroxicam in the rat. J. Biopharm. Drug Dispos. 11:215–225 (1990).
J. E. Peris-Ribera, F. Tores-Molina, M. C. Garcia-Carbonell, J. C. Astorina and J. M. Pla-Delfina. Pharmacokinetics and bioavailability of diclofenac in the rat. J. Pharmacokin. Biopharm. 19:647–665 (1991).
P. Hambleton and P. Miller. Studies on carrageenan air pouch inflammation in the rat. Br. J. Exp. Path. 70:425–433 (1989).
J. H. Satterwhite and F. D. Boudinot. Effect of age and dose on the pharmacokinetics of ibuprofen in the rat. Drug Met. Dispos. Biol. Fate. Chem. 20: 61–67 (1991).
J. R. Hales. Radioactive microspheres technique for studies of the circulation. Clin. Exp. Pharmacol. Physiol. 1:31–46 (1974).
Rights and permissions
About this article
Cite this article
Stevens, A.J., Martin, S.W., Brennan, B.S. et al. Regional Drug Delivery II: Relationship Between Drug Targeting Index and Pharmacokinetic Parameters for Three Non-Steroidal Anti-Inflammatory Drugs Using the Rat Air Pouch Model of Inflammation. Pharm Res 12, 1987–1996 (1995). https://doi.org/10.1023/A:1016212510900
Issue Date:
DOI: https://doi.org/10.1023/A:1016212510900